跳至主要内容
临床试验/NCT00693251
NCT00693251已完成4 期

Phase IV Study of Optimal Stenting Strategy For True Bifurcation Lesions

Seung-Jung Park12 个研究点 分布在 1 个国家目标入组 420 人开始时间: 2008年1月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
420
试验地点
12
主要终点
Angiographic binary restenosis rate (diameter stenosis >= 50%) at 8 months in either main or side branch

研究概览

简要总结

It is unclear which stenting strategy will be optimal for true bifurcation coronary lesions.

详细描述

The outcome of percutaneous coronary intervention of bifurcation lesions with bare-metal stents is hindered by increased rates of procedural complications and long-term major adverse cardiac events compared with non-bifurcated lesions.1 Randomized studies have demonstrated that drug-eluting stents reduce restenosis when used in relatively simple lesions; and recent data have demonstrated efficacy of the sirolimus-eluting stent for bifurcation lesions compared with historical data of BMS. In one study of bifurcation lesions, the overall restenosis rate was 23%, with the majority of side branch restenoses occurring at the ostium after use of a T-stenting technique. Indeed, side branch restenosis occurred in 16.7% after T-stenting, compared with 7.1% after other stenting techniques.

The "crush" technique of bifurcation stenting with DESs was introduced by Colombo et al. in 2003 as a relatively simple technique that ensures complete coverage of the side branch ostium, thereby facilitating drug delivery at this site. Initial data of 20 patients treated with this technique with SES suggest that it is a safe method, with an acceptable rate of procedural complications and no further adverse events up to 30 days follow-up. Recently, angiographic data have shown the importance of simultaneous kissing balloon post-dilation in reducing restenosis and need for target lesion revascularization. They also reported that compared to T-stenting, crushing with final kissing balloon dilatation was associated with lower rate of restenosis and target lesion revascularization. Consequently, the crushing is currently most promising technique in treating bifurcation lesions using two stents. However, despite the advance of bifurcation stenting technique, the superiority of bifurcation stenting with crushing technique over simple stenting in bifurcation lesion has not been demonstrated.

Therefore, we conducted the prospective randomized study comparing crushing technique with final kissing balloon dilatation and a simple technique (main vessel stenting and provisional T-stenting) for treatment of true bifurcation lesions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with angina and documented ischemia or patients with documented silent ischemia
  • Patients who are eligible for intracoronary stenting
  • Age >18 years, <75 ages
  • Angiographic
  • De novo lesion located in a major bifurcation point with the MEDINA classification type 1.1.0, 1.0.0, or 0.1.0
  • Main vessel : >= 2.5 mm in vessel size, >= 50% in diameter stenosis and =< 50 mm in lesion length by visual estimation, in which the lesion seems to be covered with =< 2 stents
  • Side branch : >= 2.0 mm in vessel size, >= 50% in diameter stenosis, and < 20 mm in lesion length by visual estimation, in which the lesion seems to be covered with single stent

排除标准

  • History of bleeding diathesis or coagulopathy
  • Known hypersensitivity or contra-indication to contrast agent, heparin, sirolimus and paclitaxel
  • Limited life-expectancy (less than 1 year) due to combined serious disease
  • ST-elevation acute myocardial infarction < 2 weeks
  • Characteristics of lesion:
  • Left main disease
  • In-stent restenosis
  • Graft vessels
  • Chronic total occlusion
  • TIMI flow =< grade 2 in the side branch
  • Renal dysfunction, creatinine >= 2.0mg/dL
  • Contraindication to aspirin, clopidogrel or cilostazol
  • LV ejection fraction =< 35%

结局指标

主要结局

Angiographic binary restenosis rate (diameter stenosis >= 50%) at 8 months in either main or side branch

时间窗: 8 months

次要结局

  • Influence of bifurcation angle(8 months)
  • Amount of contrast agent(baseline)
  • FFR assessment in the side branch(baseline and 8 months)
  • Influence of new three segment bifurcation QCA software(8 months)
  • Fluoroscopic time(baseline)
  • Procedure time(baseline)
  • Reocclusion rate at the side branch at 8 month angiographic follow-up(8 months)
  • Restenosis rate at the main vessel and/or side branch(8 months)
  • Number of used stents(baseline)
  • Composite of major cardiac adverse events (MACE) including death, MI, stent thrombosis and ischemia-driven target vessel revascularization(2 years)
  • Late loss at the main vessel and the side branch(8 months)

研究者

发起方
Seung-Jung Park
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Seung-Jung Park

MD,PhD, Chairman,Heart Institute, Asan Medical Center,University of Ulsan,College of Medicine

CardioVascular Research Foundation, Korea

研究点 (12)

Loading locations...

相似试验